2020
17/07/2020
Laboratorio Fidia Farmacéutica will begin distibution of the three ophthalmic products it recently acquired from the multinational company Novartis.
Fidia's Spanish affiliate, Laboratorio Fidia Farmacéutica, has announced today that, starting in…
29/06/2020
Laboratoires Fidia is pleased to announce the launch of its new Hymovis website, after the…
18/06/2020
Fidia Pharma Russia is pleased to announce the launch of its new Hyalone website, after the recent…
10/06/2020
Fidia is pleased to announce the launch of its new Hy-tissue website at www.hy-tissue.com.The…
06/05/2020
The company has undertaken extensive safety measures for its employees straight after the outbreak, while ensuring continuity of operations and production
Abano Terme (PD), May 5th 2020 – Fidia, Italian multinational company, with R&D, manufacturing,…
27/04/2020
Health and safety, a top priority for Fidia
According to Fidia Farmaceutici S.p.A mission and policy, health and safety of people, and of course…
11/03/2020
Fidia has implemented a series of measures, to minimize any potential risks related with the…
10/03/2020
Fidia proudly supports the important aim of the World Sleep Day and launches the SLEEP&HEART…
13/01/2020
The Italian Group has announced a new commercial agreement with the multinational company Novartis for high-level products
Fidia has recently announced a new commercial partnership with the Italian subsidiary of Novartis…
02/12/2019
Fidia's wholly owned subsidiary, Fidia Pharma USA Inc., introduces in the US, TRILURON™ , a…
02/09/2019
The Italian company has announced two major investments in Spain with the acquisition of three ophthalmic products on the Spanish market from the multinational company Novartis, and the acquisition of the Spanish company Soluciones Bioregenerativas SL.
Fidia, an Italian multinational pharmaceutical company, has announced the acquisition of three…
